India announces 200 scholarships for Syrian students

New Delhi [India], October 2 (ANI): Dr. Ausaf Sayeed, Secretary (CPV & OIA), during his visit to Syria,...

New drug helps relieve eczema's terrible itch

Illinois [US], September 19 (ANI): Researchers involved in a new multi-site international phase III study led by...

Biological E announces CDSCO's approval of its PCV14 vaccine

Hyderabad (Telangana) [India] September 1 (ANI): Hyderabad-based vaccines manufacturer Biological E Limited...

Bharat Biotech completes clinical development for nasal vaccine

Hyderabad (Telangana) [India], August 15 (ANI): Bharat Biotech International on Monday said that BBV154 (intranasal...

BB's COVID-19 nasal vaccine phase III trials completed

Paris [France], June 19 (ANI): Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local...

Delhi Police bust IPL betting racket, arrest six persons

New Delhi [India], May 22 (ANI): Delhi Police busted an IPL betting racket in Chander Vihar, Phase-III, Nihal Vihar...

Clinical trial on efficacy of Ayurveda in treatment of rheumatoid

New Delhi [India], March 23 (ANI): To examine the efficacy of Ayurveda in the treatment of Rheumatoid Arthritis, the...

Phase 2,3 trial data of India's first mRNA COVID vaccine...

New Delhi [India], March 18 (ANI): Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III...

AstraZeneca booster dose works against Omicron, says Oxford...

London [UK], December 23 (ANI): The University of Oxford, in collaboration with AstraZeneca, has announced interim...

Patients with high-risk local melanomas benefit from...

Pennsylvania [US], September 20 (ANI): According to the results of an international, randomized phase III clinical...

Optimus announces Interim Clinical Results from Phase III...

Hyderabad (Telangana) [India], July 21 (ANI/PNN): Optimus Pharma on Sunday submitted the interim result of Phase III...

Hetero announces interim clinical results from Phase III...

Hyderabad (Telangana) [India], July 9 (ANI): Hetero, a globally renowned vertically integrated pharmaceutical...